Faes Farma, a Basque pharmaceutical company, is advancing its international expansion strategy by signing a conditional agreement to acquire 100% of Laboratorios Edol, a Portuguese pharmaceutical firm, for €75 million. This acquisition aims to enhance Faes Farma's operations in Portugal. Additionally, Ukrainian company MHP has increased its stake in Uvesa to 50.54%, reflecting its growing interest in the Spanish poultry market.